TH-SC01 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
96クローン病2

96. クローン病


臨床試験数 : 2,442 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05626023
(ClinicalTrials.gov)
November 30, 202226/10/2022A Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's DiseaseA Phase I Study to Evaluate the Safety and Tolerability of Human TH-SC01 Cell Injection for the Treatment of Perianal Fistulas in Crohn's DiseasePerianal Fistula;Crohn's DiseaseDrug: Human TH-SC01 cell injectionJiangsu Topcel-KH Pharmaceutical Co., Ltd.Changhai HospitalNot yet recruiting18 Years70 YearsAll9Phase 1/Phase 2NULL
2NCT04939337
(ClinicalTrials.gov)
November 12, 202010/6/2021A Study of TH-SC01 for Treating Complex Perianal Fistula in Perianal Crohn's Disease.Study to Assess the Safety and Efficacy of Allogeneic Umbilical Cord-derived Mesenchymal Stem Cells(TH-SC01), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease.Crohn's DiseaseDrug: TH-SC01Jinling Hospital, ChinaJiangsu Topcel-KH Pharmaceutical Co., LtdEnrolling by invitation18 Years70 YearsAll24Phase 1China